In this fourth episode of OncChats: Examining LIFU–Aided Liquid Biopsy in Glioblastoma, Manmeet Singh Ahluwalia, MD, MBA, FASCO, and Michael W. McDermott, MD, discuss the key objectives of the phase 3 LIMITLESS study (NCT05317858) examining low-intensity focused ultrasound with immunotherapy and chemotherapy in patients with lung cancer and brain metastases.

Related Keywords

Florida , United States , Toronto , Ontario , Canada , Manmeet Singh Ahluwalia , Michaelw Mcdermott , University Of Toronto , Baptist Health South Florida , Aided Liquid Biopsy , Salifu , Ultrasound , Glioblastoma , Limitless Trial , D , Brain Metastases , Lung Cancer , Lung Cancer And Brain Metastases , Immunotherapy , Chemotherapy , Mayo Clinic , Non Small Cell Lung Cancer , Onclive , Oncchats , Liquid Biopsy , Low Intensity Focused Ultrasound ,